Crossword Cybersecurity’s Identiproof demonstrates early commitment to Open Badges V3 in the Jobs for the Future Plugfest
7 July 2022 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
7 July 2022 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
Study demonstrated device functioned as designed when administered with food, potentially enabling non-fasted administration SAN…
Scientific expertise and financial strength will be a boost for the Michigan cannabis market SANTA…
AVT06 is the third biosimilar candidate developed by Alvotech to enter clinical studies Eylea® (aflibercept)…
The new facility will serve the JV’s development of potential cancer drugs TEL AVIV, Israel,…
President Tom Dubensky, Ph.D., to Share Expertise on Next Generation Immuno-Oncolgy Targets SOUTH SAN FRANCISCO, Calif.,…
Mina Sooch CEO to Present at Ophthalmic Innovation Panel at the 11th Annual AECOS Summer…
July 7, 2022 at 8:00 AM EDT GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 07, 2022 (GLOBE…
Advances asset in the neuro-endocrine orphan disease space SCOUT-015 clinical trial currently has 9 activated…
Thursday, July 14, 2022 @ 11:30 a.m. ET DURHAM, N.C., July 07, 2022 (GLOBE NEWSWIRE)…
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic pharmaceutical…
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) — As part of its ongoing commitment to…
MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company…
Uplisting is the Next Significant Step FRAMINGHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) — Arch…
The Company Continues to Evaluate Optimal Dosing for Patients with Acute Myeloid Leukemia and Lymphoma…
New Suppliers Will Increase Access to Unique Banked Biospecimens for Advancing Oncology and Cardiovascular Disease…
Avicanna News Avicanna News The exclusive distribution agreement with Bio-Gate AG includes 5 SKUs from…
MONTREAL, July 07, 2022 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a…
OCA 25 mg met the agreed primary endpoint of improvement in liver fibrosis without worsening…